J3403
HCPCSRevakinagene, per implant
Official HCPCS Level II long descriptor
Revakinagene taroretcel-lwey, per implant
HCPCS Level II code J3403 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Revakinagene, per implant
Added to HCPCS: 2025-10-01
Nearby codes in J3
- J3393Inj, betibeglogene autotemce
- J3394Inj, lovotibeglogene autotem
- J3396Verteporfin injection
- J3397Inj., vestronidase alfa-vjbk
- J3398Inj luxturna 1 billion vec g
- J3399Inj onase abepar-xioi treat
- J3401Vyjuvek 5x10^9pfu/ml, 0.1 ml
- J3402Inj. remestemcel-l-rknd/ td
- J3404Inj zopapogene per ther dose
- J3405Inj onase abepar-brve treat
- J3410Hydroxyzine hcl injection
- J3411Thiamine hcl 100 mg
- J3415Pyridoxine hcl 100 mg
- J3420Vitamin b12 injection
- J3424Inj hydroxocobalamin iv 25mg
- J3425Hydroxocobalamin im 10mcg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.